Argentina, Monsanto finalize agreement on GMO royalties

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Monsanto Co. and Argentina announced an agreement for the collection of royalties for genetically modified soybeans, ending years of dispute between the world’s largest seed company and the third-largest grower of the crop.

“The state will have full control of seed commercialization in order to ensure private companies like Monsanto will be able to collect royalties payments,” Agriculture Minister Ricardo Buryaile said [June 23] . . . “That is the spirit of the resolution.”

The pact represents a cultural shift for Argentine farmers, who have generally avoided paying royalties to seed companies by using GMO seeds saved from previous harvests or purchased from non-registered suppliers. For . . . Monsanto, the agreement should help it secure revenue from its third-largest market after the U.S. and Brazil.

According to the resolution, the Argentine Seed Institute, also known by its Spanish acronym Inase, will oversee the detection of crops from Monsanto’s Intacta GMO soybean seeds. . . .

Read full, original post: Monsanto Seals GMO Pact With Argentina to End Soybean Dispute

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-PM-24
Viewpoint: The herbicide glyphosate isn’t perfect. Banning it would be far worse.
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
images
The never-ending GMO debate: Pros and cons
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
ChatGPT-Image-May-1-2026-02_20_13-PM
How RFK, Jr.’s false vaccine claims are holding up $600 million to fight diseases in poor countries
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.